HEADER TRANSCRIPTION 07-JAN-20 6VG8 TITLE CRYSTAL STRUCTURE OF THE DNA BINDING DOMAINS OF HUMAN FLI1 AND RUNX2 TITLE 2 IN COMPLEX WITH 16-MER DNA CAGAGGATGTGGCTTC COMPND MOL_ID: 1; COMPND 2 MOLECULE: FRIEND LEUKEMIA INTEGRATION 1 TRANSCRIPTION FACTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: DNA BINDING DOMAIN; COMPND 5 SYNONYM: PROTO-ONCOGENE FLI-1,TRANSCRIPTION FACTOR ERGB; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: THE N-TERMINAL GPHM SEQUENCE IS THE REMAINDER OF AN COMPND 8 AFFINITY TAG AFTER ITS CLEAVAGE AND REMOVAL.; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: DNA (5'- COMPND 11 D(P*CP*AP*GP*AP*GP*GP*AP*TP*GP*TP*GP*GP*CP*TP*TP*C)-3'); COMPND 12 CHAIN: B; COMPND 13 ENGINEERED: YES; COMPND 14 OTHER_DETAILS: SYNTHETIC DNA OLIGOMER; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: DNA (5'- COMPND 17 D(P*GP*AP*AP*GP*CP*CP*AP*CP*AP*TP*CP*CP*TP*CP*TP*G)-3'); COMPND 18 CHAIN: C; COMPND 19 ENGINEERED: YES; COMPND 20 OTHER_DETAILS: SYNTHETIC DNA OLIGOMER; COMPND 21 MOL_ID: 4; COMPND 22 MOLECULE: RUNT-RELATED TRANSCRIPTION FACTOR 2; COMPND 23 CHAIN: D; COMPND 24 FRAGMENT: DNA BINDING DOMAIN; COMPND 25 SYNONYM: ACUTE MYELOID LEUKEMIA 3 PROTEIN,CORE-BINDING FACTOR SUBUNIT COMPND 26 ALPHA-1,CBF-ALPHA-1,ONCOGENE AML-3,OSTEOBLAST-SPECIFIC TRANSCRIPTION COMPND 27 FACTOR 2,OSF-2,POLYOMAVIRUS ENHANCER-BINDING PROTEIN 2 ALPHA A COMPND 28 SUBUNIT,PEBP2-ALPHA A,SL3-3 ENHANCER FACTOR 1 ALPHA A SUBUNIT,SL3/AKV COMPND 29 CORE-BINDING FACTOR ALPHA A SUBUNIT; COMPND 30 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FLI1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 MOL_ID: 3; SOURCE 14 SYNTHETIC: YES; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_COMMON: HUMAN; SOURCE 17 ORGANISM_TAXID: 9606; SOURCE 18 MOL_ID: 4; SOURCE 19 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 20 ORGANISM_COMMON: HUMAN; SOURCE 21 ORGANISM_TAXID: 9606; SOURCE 22 GENE: RUNX2, AML3, CBFA1, OSF2, PEBP2A; SOURCE 23 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 24 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS ONCOGENESIS, EWING SARCOMA, ENHANCER, BONE CANCER, LEUKEMIA, ETS- KEYWDS 2 FAMILY, RUNT-FAMILY, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR C.HOU,O.V.TSODIKOV REVDAT 4 11-OCT-23 6VG8 1 REMARK REVDAT 3 19-MAY-21 6VG8 1 JRNL REVDAT 2 16-DEC-20 6VG8 1 JRNL REVDAT 1 25-NOV-20 6VG8 0 JRNL AUTH C.HOU,A.MANDAL,J.ROHR,O.V.TSODIKOV JRNL TITL ALLOSTERIC INTERFERENCE IN ONCOGENIC FLI1 AND ERG JRNL TITL 2 TRANSACTIONS BY MITHRAMYCINS. JRNL REF STRUCTURE V. 29 404 2021 JRNL REFN ISSN 0969-2126 JRNL PMID 33275876 JRNL DOI 10.1016/J.STR.2020.11.012 REMARK 2 REMARK 2 RESOLUTION. 4.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 4.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 7298 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.274 REMARK 3 R VALUE (WORKING SET) : 0.273 REMARK 3 FREE R VALUE : 0.283 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 409 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 4.31 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 4.42 REMARK 3 REFLECTION IN BIN (WORKING SET) : 498 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.81 REMARK 3 BIN R VALUE (WORKING SET) : 0.5130 REMARK 3 BIN FREE R VALUE SET COUNT : 31 REMARK 3 BIN FREE R VALUE : 0.6210 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1720 REMARK 3 NUCLEIC ACID ATOMS : 656 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 247.0 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.15000 REMARK 3 B22 (A**2) : 6.15000 REMARK 3 B33 (A**2) : -19.97000 REMARK 3 B12 (A**2) : 3.08000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.709 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.835 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 74.824 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.962 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2494 ; 0.003 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): 1984 ; 0.003 ; 0.018 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3509 ; 1.221 ; 1.500 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4608 ; 1.177 ; 1.844 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 214 ; 7.928 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 101 ;30.043 ;20.594 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 297 ;17.330 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;11.565 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 318 ; 0.053 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2361 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 568 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6VG8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JAN-20. REMARK 100 THE DEPOSITION ID IS D_1000246331. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300-HS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16635 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.250 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 7.900 REMARK 200 R MERGE (I) : 0.13100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.31 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.43300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5JVT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 82.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 7.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 7% W/V PEG 4000, 50 MM NA CITRATE, PH REMARK 280 5.6, 4% V/V ISOPROPANOL, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 62 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+2/3 REMARK 290 6555 X-Y,X,Z+1/3 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+2/3 REMARK 290 11555 -X+Y,Y,-Z REMARK 290 12555 X,X-Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 217.58800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 108.79400 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 217.58800 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 108.79400 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 217.58800 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 108.79400 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 217.58800 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 108.79400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 272 REMARK 465 PRO A 273 REMARK 465 HIS A 274 REMARK 465 PRO A 371 REMARK 465 HIS A 372 REMARK 465 PRO A 373 REMARK 465 THR A 374 REMARK 465 GLU A 375 REMARK 465 ARG D 231 REMARK 465 GLN D 232 REMARK 465 LYS D 233 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 303 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 276 0.46 -66.92 REMARK 500 THR A 301 148.26 -171.71 REMARK 500 THR A 312 -84.13 -76.24 REMARK 500 ASN A 346 48.32 70.14 REMARK 500 ARG A 355 90.05 -65.53 REMARK 500 TYR A 356 54.91 70.09 REMARK 500 TYR A 358 -167.25 -122.20 REMARK 500 HIS A 363 -6.20 -56.16 REMARK 500 LEU A 369 34.34 -149.91 REMARK 500 ARG D 115 173.22 -59.79 REMARK 500 PRO D 119 2.51 -69.91 REMARK 500 ASN D 133 81.68 63.93 REMARK 500 THR D 135 104.29 -53.27 REMARK 500 ASP D 150 100.27 -57.84 REMARK 500 ASP D 161 -35.89 -39.55 REMARK 500 ASN D 163 75.36 46.55 REMARK 500 VAL D 188 -62.83 -103.99 REMARK 500 PRO D 224 85.86 -66.53 REMARK 500 ARG D 229 65.38 -119.85 REMARK 500 REMARK 500 REMARK: NULL DBREF 6VG8 A 276 375 UNP Q01543 FLI1_HUMAN 276 375 DBREF 6VG8 B 1 16 PDB 6VG8 6VG8 1 16 DBREF 6VG8 C 2 17 PDB 6VG8 6VG8 2 17 DBREF 6VG8 D 111 233 UNP Q13950 RUNX2_HUMAN 111 233 SEQADV 6VG8 GLY A 272 UNP Q01543 EXPRESSION TAG SEQADV 6VG8 PRO A 273 UNP Q01543 EXPRESSION TAG SEQADV 6VG8 HIS A 274 UNP Q01543 EXPRESSION TAG SEQADV 6VG8 MET A 275 UNP Q01543 EXPRESSION TAG SEQRES 1 A 104 GLY PRO HIS MET PRO GLY SER GLY GLN ILE GLN LEU TRP SEQRES 2 A 104 GLN PHE LEU LEU GLU LEU LEU SER ASP SER ALA ASN ALA SEQRES 3 A 104 SER CYS ILE THR TRP GLU GLY THR ASN GLY GLU PHE LYS SEQRES 4 A 104 MET THR ASP PRO ASP GLU VAL ALA ARG ARG TRP GLY GLU SEQRES 5 A 104 ARG LYS SER LYS PRO ASN MET ASN TYR ASP LYS LEU SER SEQRES 6 A 104 ARG ALA LEU ARG TYR TYR TYR ASP LYS ASN ILE MET THR SEQRES 7 A 104 LYS VAL HIS GLY LYS ARG TYR ALA TYR LYS PHE ASP PHE SEQRES 8 A 104 HIS GLY ILE ALA GLN ALA LEU GLN PRO HIS PRO THR GLU SEQRES 1 B 16 DC DA DG DA DG DG DA DT DG DT DG DG DC SEQRES 2 B 16 DT DT DC SEQRES 1 C 16 DG DA DA DG DC DC DA DC DA DT DC DC DT SEQRES 2 C 16 DC DT DG SEQRES 1 D 123 ALA GLU LEU VAL ARG THR ASP SER PRO ASN PHE LEU CYS SEQRES 2 D 123 SER VAL LEU PRO SER HIS TRP ARG CYS ASN LYS THR LEU SEQRES 3 D 123 PRO VAL ALA PHE LYS VAL VAL ALA LEU GLY GLU VAL PRO SEQRES 4 D 123 ASP GLY THR VAL VAL THR VAL MET ALA GLY ASN ASP GLU SEQRES 5 D 123 ASN TYR SER ALA GLU LEU ARG ASN ALA SER ALA VAL MET SEQRES 6 D 123 LYS ASN GLN VAL ALA ARG PHE ASN ASP LEU ARG PHE VAL SEQRES 7 D 123 GLY ARG SER GLY ARG GLY LYS SER PHE THR LEU THR ILE SEQRES 8 D 123 THR VAL PHE THR ASN PRO PRO GLN VAL ALA THR TYR HIS SEQRES 9 D 123 ARG ALA ILE LYS VAL THR VAL ASP GLY PRO ARG GLU PRO SEQRES 10 D 123 ARG ARG HIS ARG GLN LYS HELIX 1 AA1 LEU A 283 LEU A 288 1 6 HELIX 2 AA2 ASP A 293 ALA A 297 5 5 HELIX 3 AA3 ASP A 313 SER A 326 1 14 HELIX 4 AA4 ASN A 331 ASN A 346 1 16 HELIX 5 AA5 ASP A 361 ALA A 366 1 6 SHEET 1 AA1 2 ILE A 300 TRP A 302 0 SHEET 2 AA1 2 PHE A 309 MET A 311 -1 O LYS A 310 N THR A 301 SHEET 1 AA2 2 MET A 348 LYS A 350 0 SHEET 2 AA2 2 TYR A 358 PHE A 360 -1 O LYS A 359 N THR A 349 SHEET 1 AA3 4 LEU D 113 VAL D 114 0 SHEET 2 AA3 4 PHE D 121 SER D 124 -1 O CYS D 123 N VAL D 114 SHEET 3 AA3 4 PHE D 140 ALA D 144 -1 O VAL D 143 N LEU D 122 SHEET 4 AA3 4 VAL D 179 PHE D 182 -1 O ALA D 180 N VAL D 142 SHEET 1 AA4 2 HIS D 129 ARG D 131 0 SHEET 2 AA4 2 LYS D 218 THR D 220 1 O LYS D 218 N TRP D 130 SHEET 1 AA5 4 SER D 172 VAL D 174 0 SHEET 2 AA5 4 VAL D 153 MET D 157 -1 N VAL D 154 O ALA D 173 SHEET 3 AA5 4 THR D 200 PHE D 204 -1 O THR D 200 N MET D 157 SHEET 4 AA5 4 GLN D 209 VAL D 210 -1 O GLN D 209 N VAL D 203 SHEET 1 AA6 2 LEU D 168 ARG D 169 0 SHEET 2 AA6 2 ARG D 186 PHE D 187 -1 O ARG D 186 N ARG D 169 CISPEP 1 ASN D 206 PRO D 207 0 0.21 CRYST1 104.427 104.427 326.382 90.00 90.00 120.00 P 62 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009576 0.005529 0.000000 0.00000 SCALE2 0.000000 0.011057 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003064 0.00000